Patents Assigned to CZ BIOMED CORP.
  • Lung cancer therapy using an engineered respiratory syncytial virus
    Publication number: 20130251680
    Abstract: The invention discloses an engineered oncolytic respiratory syncytial virus (RSV), NS1 gene deficient RSV, and its usage to treat lung cancer by killing cancer cells with in vitro and in vivo evidences.
    Type: Application
    Filed: March 8, 2013
    Publication date: September 26, 2013
    Applicant: CZ BIOMED CORP.
    Inventors: Weidong Zhang, Lixian Jiang, Calvin Cao